Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.
about
Recurrent aseptic meningitis in association with Kikuchi-Fujimoto disease: case report and literature reviewEpstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationIncreased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production.Biomarkers in systemic lupus erythematosus: challenges and prospects for the future.MicroRNA-466l inhibits antiviral innate immune response by targeting interferon-alpha.Strong viral associations with SLE among Filipinos.The Possible Effect of B-Cell Epitopes of Epstein–Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus.Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
P2860
Q21261393-346019CD-6B36-4B29-95E1-C02A43768F23Q26830464-CFFA3860-1977-44B9-AEB3-08A57A9CFE1BQ35845445-1F6E03D1-10BC-4876-ACDB-26C244F39CB9Q37058781-1BCA950D-D7AD-49A7-A366-FC1EA7E38925Q37727846-FD0746F3-565B-4277-A95E-7975018B8CA3Q46461196-81277CF6-ED37-40DF-B662-4A0AB818547CQ50347150-D5D64C0D-BFEA-49ED-868A-FD2344526812Q51770480-725397ED-3A6C-4343-81AA-6A575633BE48Q52867190-101B95D4-9084-4664-8A3A-480732101477
P2860
Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activation of type I interfero ...... distinct clinical phenotypes.
@ast
Activation of type I interfero ...... distinct clinical phenotypes.
@en
Activation of type I interfero ...... distinct clinical phenotypes.
@nl
type
label
Activation of type I interfero ...... distinct clinical phenotypes.
@ast
Activation of type I interfero ...... distinct clinical phenotypes.
@en
Activation of type I interfero ...... distinct clinical phenotypes.
@nl
prefLabel
Activation of type I interfero ...... distinct clinical phenotypes.
@ast
Activation of type I interfero ...... distinct clinical phenotypes.
@en
Activation of type I interfero ...... distinct clinical phenotypes.
@nl
P2093
P2860
P921
P356
P1476
Activation of type I interfero ...... distinct clinical phenotypes.
@en
P2093
Clio P Mavragani
Dimitrios D Tseronis
Theophanis P Karageorgas
P2860
P304
P356
10.1155/2011/273907
P577
2011-11-16T00:00:00Z